102 related articles for article (PubMed ID: 4147272)
1. The pharmacological characterization of beta-sympathicolytic substances.
Saameli K
Indian Heart J; 1972 Jun; 24():Suppl 1:146-56. PubMed ID: 4147272
[No Abstract] [Full Text] [Related]
2. Bamethan A competitive betamimetic drug.
Marmo E; Saini RK; Caputi AP
Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):247-72. PubMed ID: 4152789
[No Abstract] [Full Text] [Related]
3. [Pharmacological study of a new beta adrenergic inhibitor (S 2395)].
Laubie M; Schmitt H; Mouillé P; Cheymol G; Gilbert JC
C R Acad Hebd Seances Acad Sci D; 1971 Oct; 273(14):1234-6. PubMed ID: 4399407
[No Abstract] [Full Text] [Related]
4. [Search for new beta-adrenoblockaders among derivatives of (3-amino-2-hydroxypropoxy) phenoxymethyl isoxazole].
Iuzhakov SD; Sokolov SD; Vinogradova SM
Farmakol Toksikol; 1988; 51(4):47-52. PubMed ID: 2903834
[TBL] [Abstract][Full Text] [Related]
5. [Beta adrenolytic activity and hemodynamic effects of penbutolol].
Boissier JR; Coutte R; Advenier C; Giudicelli JF
Therapie; 1973; 28(6):1251-65. PubMed ID: 4152643
[No Abstract] [Full Text] [Related]
6. Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent.
Darias V; del Río J
Arzneimittelforschung; 1974 Nov; 24(11):1756-9. PubMed ID: 4155633
[No Abstract] [Full Text] [Related]
7. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of GYKI-41 099 (chlorpropanol, Tobanum) a new potent beta-adrenergic antagonist.
Fekete MI; Elekes I; Kürti M; Borvendég J
Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):190-202. PubMed ID: 6111982
[TBL] [Abstract][Full Text] [Related]
9. [Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system].
Takenaka F; Ishihara T; Maruyama Y; Matsumoto S; Inoue H
Nihon Yakurigaku Zasshi; 1974 May; 70(3):385-97. PubMed ID: 4155394
[No Abstract] [Full Text] [Related]
10. Comparison of the beta receptor blocking properties of two analogs of dichloroisoproterenol (DCI).
Levy B
J Pharmacol Exp Ther; 1973 Jul; 186(1):123-33. PubMed ID: 4146700
[No Abstract] [Full Text] [Related]
11. Evaluation of beta-adrenolytic properties of N,N'-bis-(3-(p-methoxyphenoxy)-2-hydroxypropyl)-ethylenediamine and its N,N'-dimethyl derivative.
Robak J; Grodzińska L
Pol J Pharmacol Pharm; 1973; 25(3):253-7. PubMed ID: 4150018
[No Abstract] [Full Text] [Related]
12. Comparative study of beta-adrenoceptor blocking efficacy of two formulations of esmolol in vivo and in vitro.
Tripathi CB; Bhattacharya P; Bhatt JD; Hemavathi KG
Indian J Physiol Pharmacol; 1999 Apr; 43(2):255-8. PubMed ID: 10365322
[TBL] [Abstract][Full Text] [Related]
13. [Use of beta blockaders in arrhythmias and ischemic heart disease].
Rosselot E
Rev Med Chil; 1982 Dec; 110(12):1224-32. PubMed ID: 6135249
[No Abstract] [Full Text] [Related]
14. Puerarin beta-adrenergic receptor blocking effect.
Lu XR; Gao E; Xu LZ; Li HZ; Kang B; Chen WN; Chen SM; Chai XS
Chin Med J (Engl); 1987 Jan; 100(1):25-8. PubMed ID: 2885157
[No Abstract] [Full Text] [Related]
15. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
Ferrini R; Miragoli G; Croce G
Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
[No Abstract] [Full Text] [Related]
16. Pharmacological evidence for differences in the beta-adrenoceptor populations influencing atrial rate in guinea pig and cat.
O'Donnell SR; Wanstall JC
Circ Res; 1980 Jun; 46(6 Pt 2):I55-6. PubMed ID: 6247096
[TBL] [Abstract][Full Text] [Related]
17. [Proxodolol--a new beta- and alpha-adrenoblockader].
Iuzhakov SD; Dolgun OV; Dorodnikova EV; Aniukhovskiĭ EP; Baldenkov GN; Rozenshtraukh LV; Medvedev OS; Mashkovskiĭ MD
Eksp Klin Farmakol; 1994; 57(3):30-3. PubMed ID: 7914115
[TBL] [Abstract][Full Text] [Related]
18. Beta receptor blocking and antiarrhythmic properties of tolamolol.
Bagwell EE; Custy J; Steen RG; Newman WH
J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
[No Abstract] [Full Text] [Related]
19. Changes in beta-adrenoceptor-blocking activity produced by chemical modifications in the practolol molecule.
Weinstock M; Schechter Y; Erez M; Shtacher G
Eur J Pharmacol; 1974 May; 26(2):191-7. PubMed ID: 4152806
[No Abstract] [Full Text] [Related]
20. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
Nayler WG; Tay J
J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
